Die Primärbehandlung von fortgeschrittenen Rektumkarzinomen besteht aus Operation
und Bestrahlung. Zurzeit erreicht man die besten Ergebnisse durch eine Kombination
von optimaler TME (total mesorektaler Excision) und präoperativer Radiotherapie bzw.
Radio-/Chemotherapie. In diesen Fällen lässt sich das Rezidivrisiko auf fast Null
zurückfahren. Die Bestrahlung kann im Ergebnis eine inadäquate Operation verbessern,
kann sie aber nicht ersetzen.
Primary treatment of advanced rectal cancer consists of surgery and radiotherapy.
Combining optimal TME (total mesorectal excision)-surgery-technique with preoperative
radiotherapy or radiochemotherapy. In these cases recurrences are very rare. Irradiation
can partly compensate for the results of inadequate surgery but cannot replace it.
Key words
Rectum carcinoma - irradiation - short course irradiation - combined radiochemotherapy
- side effects - results
Literatur
- 1
MacFarlane JK, Ryall RD, Heald RJ.
Mesorectal excision for rectal cancer.
Lancet.
1993;
341
457-460
- 2 Hohenberger W. The effect of specialization or organization of rectal cancer surgery.
In: Soreide O, Norstein J, (eds.) Rectal cancer surgery: optimization, standardization,
documentation. Berlin: Springer-Verlag; 1997: 353-363
- 3
Sauer R, Becker H, Hohenberger W et al..
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer.
N Engl J Med.
2004;
351
1731-1740
- 4
Sebag-Montefiore D, Stephens RJ, Steele R et al..
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients
with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trail.
Lancet.
2009;
373
811-820
- 5
Ulrich A, Weitz J, Büchler MW.
Strahlentherapie bei Rektumkarzinom. Wird zu viel bestrahlt?.
Chirurg.
2009;
80
266-273
- 6
Pollack J, Holm T, Cedermark B.
Late adverse effects of short-course preoperative radiotherapy in rectal cancer.
Br J Surg.
2006;
93
1519-1525
- 7
Birgisson H, Pahlmann L, Gunnarsson U, Glimelius B.
Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up
of the Swedish Rectal Cancer Trail.
J Clin Oncol.
2005;
23
8697-8705
- 8
Bujko K, Nowacki MP, Nasierowska-Guttmejer A Polish Colorectal Study Group et al..
Long-term results of a randomized trail comparing preoperative short-course radiotherapy
with preoperative conventionally fractionated chemoradiation for rectal cancer.
British Journal of Surgery.
2006;
93
1215-1223
- 9
McLachlan S, Fisher R, McLure B.
A comparison of quality of life in patients with T3 rectal cancer receiving short
course vs long course preoperative radiation. A Trans-Tasman Radiation Oncology Group
Trail (TROG 01.04).
Proc Am Soc Clin Oncol.
(abstr 4097)
2008;
26
- 10
Folkesson J, Birgisson H, Pahlmann L et al..
Swedish Rectal Cancer Trail: long lasting benefits from radiotherapy on survival and
local recurrence rate.
J Clin Oncol.
2005;
23
5644-5650
- 11
Vermaas M, Ferenschild FTJ, Nuyttens JJME et al..
Präoperative Strahlentherapie verbessert das Ergebnis bei Rezidiven eines Rektumkarzinoms.
Coloproctology.
2006;
28
85-96
Korrespondenz
Prof. Dr. med. Wolfgang Wagner
Ärztlicher Direktor Paracelsus-Strahlenklinik Osnabrück
Am Natruper Holz 69
49076 Osnabrück
Fax: 0541/9664879
eMail: prof.wolfgang.wagner@pk-mx.de
